Author

L. M. Dillon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pathology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Organism:human· 2 Assay:imaging· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Organism:mouse· 1

Frequent Co-Authors

J. B. Wojcik· 2 shared A. Sanders-Cliette· 1 shared A. Vandebroek· 1 shared B. McCune· 1 shared C. F. McCleery· 1 shared C. Hedvat· 1 shared C. Rypens· 1 shared C. Schroyer· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

J. B. Wojcik

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Development of a LAG-3 Immunohistochemistry Assay for Melanoma

L. Johnson, B. McCune, D. Locke, C. Hedvat, J. B. Wojcik, C. Schroyer, J. Yan, K. Johnson, A. Sanders-Cliette, S. Samala, L. M. Dillon, S. Anderson, J. Shuster

This paper develops a LAG-3 immunohistochemistry assay for melanoma, demonstrating high specificity, sensitivity, and reproducibility for clinical use.

bioRxiv · Feb 25, 2022Pathology

Consistent measurement of LAG-3 expression across multiple staining platforms with the 17B4 antibody clone

J. B. Wojcik, K. Desai, K. Avraam, A. Vandebroek, L. M. Dillon, G. Giacomazzi, C. Rypens, J. Benci

This study evaluates the consistency of LAG-3 IHC assays using the 17B4 antibody across three staining platforms, finding high correlation and agreement.

bioRxiv · Feb 21, 2022Pathology

AMPK activation by metformin promotes survival of dormant ER+ breast cancer cells

R. A. Hampsch, J. D. Wells, N. A. Traphagen, C. F. McCleery, J. L. Fields, K. Shee, L. M. Dillon, D. B. Pooler, L. D. Lewis, E. Demidenko, Y. H. Huang, J. D. Marotti, W. Kinlaw, T. W. Miller

This study shows that metformin promotes survival of dormant ER+ breast cancer cells by increasing mitochondrial respiration through fatty acid oxidation, suggesting caution in using AMPK activators with anti-estrogens.

bioRxiv · Jan 21, 2020Cancer Biology